Atlas Trials

Iron Substitution With Ferric Carboxymaltose as Treatment Strategy for Heart Failure Patients With Preserved Ejection Fraction

Clinical trial NCT05477498 · WITHDRAWN

Trial details

NCT number
NCT05477498
Sponsor
Cantonal Hosptal, Baselland
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Heart Failure With Normal Ejection FractionIron-deficiency
Start date
2021-12-01
Primary completion
2022-08-31
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.